In vivo studies of endotoxin removal by lysine-cellulose adsorbents

被引:66
作者
Fang, H [1 ]
Wei, H [1 ]
Yu, YT [1 ]
机构
[1] Nankai Univ, Key Lab Bioact Mat, Minist Educ, Tianjin 300071, Peoples R China
关键词
endotoxin; lysine; cellulose; hemoperfusion; sepsis;
D O I
10.1016/j.biomaterials.2003.12.035
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A new type adsorbent for removal of bacterial endotoxins was prepared by immobilizing lysine covalently onto cellulose beads. Endotoxins (Escherichia coli O55: B5) were injected into 13 healthy New Zealand white rabbits to induce infectious symptoms. Hemoperfusion using the adsorbent column removed endotoxins in the blood of eight rabbits during 2h while other five rabbits were used as control. The mean blood endotoxin concentration was reduced significantly from 5.56 +/- 0.54 EU/ml (I EU = 100 pg) before treatment to 0.41 +/- 0.26 EU/ml after perfusion as measured by the limulus amebocyte lysate test (Chromogenix). Liver function and renal function tests showed significant improvement of septic symptoms in contrast to the control group. Other parameters such as superoxide dismutase and malondialdehyde were ameliorated markedly after the treatment. Moreover, the adsorbent showed good results in mechanical strength, blood compatibility and cytotoxicity, which suggested that lysine-cellulose adsorbent was of high ET-binding efficacy without significant side effect. It has a high potential of clinical application for treatment of patients with severe sepsis. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5433 / 5440
页数:8
相关论文
共 33 条
[1]   AN OVERVIEW OF MORTALITY RISK PREDICTION IN SEPSIS [J].
BARRIERE, SL ;
LOWRY, SF .
CRITICAL CARE MEDICINE, 1995, 23 (02) :376-393
[2]   Hemodynamic effects of plasma exchange in septic patients: Preliminary report [J].
Berlot, G ;
Gullo, A ;
Fasiolo, S ;
Serra, L ;
Silvestri, L ;
Worz, M .
BLOOD PURIFICATION, 1997, 15 (01) :45-53
[3]   SEPSIS SYNDROME - A VALID CLINICAL ENTITY [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
CRITICAL CARE MEDICINE, 1989, 17 (05) :389-393
[4]  
CALLERY MP, 1991, ARCH SURG-CHICAGO, V126, P28
[5]   Systemic inflammatory response syndrome [J].
Davies, MG ;
Hagen, PO .
BRITISH JOURNAL OF SURGERY, 1997, 84 (07) :920-935
[6]  
Grootendorst A F, 1994, Adv Ren Replace Ther, V1, P176
[7]  
HANASAWA K, 1989, SURG GYNECOL OBSTET, V168, P323
[8]   Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration [J].
Heering, P ;
Morgera, S ;
Schmitz, FJ ;
Schmitz, G ;
Willers, R ;
Schultheiss, HP ;
Strauer, BE ;
Grabensee, B .
INTENSIVE CARE MEDICINE, 1997, 23 (03) :288-296
[9]  
Horn DL, 1996, SCAND J INFECT DIS, P9
[10]  
KANEKO JJ, 1980, CLIN BIOCH DOMESTIC, P230